Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 8—August 2025
Dispatch
Microsporidial Keratoconjunctivitis Caused by Vittaforma corneae, Sea of Galilee, Israel, 2022–2024
Figure

Figure. Slit-lamp photos of 3 patients before and after treatment of microsporidial keratoconjunctivitis caused by Vittaforma corneae, Sea of Galilee, Israel, 2022–2024. A) Patient 1 before treatment, visual acuity 0.8 decimal. B) Patient 2 before treatment, visual acuity 0.3 decimal. C) Patient 3 before treatment, visual acuity 0.3 decimal. D) Patient 1 after treatment, visual acuity 1 decimal. E) Patient 2 after treatment, visual acuity 1 decimal. F) Patient 3 after treatment, visual acuity 1 decimal. Clinical manifestations in all 3 patients included corneal epithelial microsporidial infiltrates and conjunctival irritation. After treatment with 0.02% topical chlorhexidine, the infiltrates resolved without scarring or other complications.